OZURDEX dexamethasone 700 microgram intravitreal implant Australia - English - Department of Health (Therapeutic Goods Administration)

ozurdex dexamethasone 700 microgram intravitreal implant

abbvie pty ltd - dexamethasone, quantity: 700 microgram - implant - excipient ingredients: polyglactin - ozurdex is indicated for the treatment of:,- diabetic macular oedema (dme),- macular oedema due to branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).,- non-infectious uveitis affecting the posterior segment of the eye. ozurdex is indicated for the treatment of diabetic macular oedema (dme).